Asthma Clinical Trial
Official title:
STUDY NUMBER: PMC-101-APT Usability and Adherence of Spiromax® Inhaler Device, Turbohaler® and Diskus® Inhaler Devices for Fixed Combination of Corticosteroid/Long-acting beta2- Agonist, in Adults With Asthma or COPD
This is a randomized, multi-center, active-controlled, repeated measures design study in male
and female patients 60 years of age and older with persistent asthma or COPD.
Study will be conducted in 4 Italian University/Hospital Centers: Ferrara, Parma, Cassano
delle Murge (Ba), Tradate.
The primary efficacy parameter of the study is inhaler device usability (expressed as total
number of repeated attempts required to achieve optimal use).
Asthma and Chronic Obstructive Pulmonary Disease (COPD) are common conditions with an
increasing prevalence worldwide. Inhaled therapy for these conditions has a number of
advantages over systemic therapy, including reduced side effects and quicker onset of action.
However, poor asthma control is common, despite available effective treatment .This is
partially related to low adherence and to difficulties in using inhaler devices. Among
patients with chronic respiratory disorders, 18% discontinued the prescribed inhaler
treatment because of troubles with the device (Santus 2012). Some devices are not easy to
handle, or require breathing abilities, which reduce the effectiveness in real life,
especially in elderly.Since mistakes in inhaler technique are very common affecting drug
delivery and efficacy, a correct inhaler technique training is fundamental. A single site
study in 2012 (Press 2012) found that patients given verbal and written instructions followed
by demonstrations of inhaler use had better inhaler technique than patients given verbal and
written instructions only. The authors concluded that larger multi-centred studies were
needed to evaluate hospital-based-education.
Proposals to improve inhalers use are based on three key points:
- the choice of the best device paying attention to patient needs and abilities
(personalized therapy)
- a complete explanation of the correct use (patient training)
- a regular re-check to evaluate the maintenance of a correct technique (monitoring)
The study consists of two phases:
- A cross over phase: 3 periods of 1 week each. During the training visit at the beginning
of each week period, patients will be instructed on the correct use of one of the 3
devices. Correct use and maintenance of correct use after 1 week will be assessed.
- A longitudinal phase: patient will be treated with the last inhaler device used during
the cross over phase for 8 additional weeks.
The maximum time from screening to end of study visit is12 weeks, with a follow up taking
place 30 days after the final visit .
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|